Anti-Human F7 Polyclonal Antibody|抗人F7多克隆抗体(靶标：人凝血因子VII)
- 货号：RB9THY060024
- 价格：面议
- 点击：559
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, IHC, WB |
| 种属反应性 | Human |
| 靶标 | Coagulation factor VII, EC:3.4.21.21, Eptacog alfa, F7, Factor VII heavy chain, Factor VII light chain, Proconvertin, SPCA, Serum prothrombin conversion accelerator |
| 免疫原 | E. coli - derived recombinant Human F7 (Ile213-Pro466). |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | P08709 |
| 背景信息 | Coagulation factor VII (F7) is a ~51 kDa protein. Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa also converts factor IX to factor IXa in the presence of tissue factor and calcium. 1. Osterud, B. et al. (1977) Proceedings of the National Academy of Sciences of the United States of America 74, 5260-4. PMID: 271951 |
| 备注 | For research use only |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 痢疾志贺氏菌单克隆抗体 | 8027 |
| 沙门氏菌单克隆抗体 | 8038 |
| 乙型副伤寒沙门氏菌单克隆抗体 | 8550 |
| A族链球菌单克隆抗体 | 8351 |
| 甲型副伤寒沙门氏菌单抗 | 7922 |
| 麻疹病毒单克隆抗体 | 7977 |
| HBeAg单克隆抗体 | 8173 |
| 新型冠状病毒（SARS-COV-2）NP蛋白单克隆抗体 | 7603 |
| 呼吸道腺病毒单克隆抗体 | 8693 |
| 大肠杆菌单克隆抗体 | 8160 |
| LP-PLA2单克隆抗体 | 8065 |
| NT-PROBNP单克隆抗体 | 7741 |
| 半乳糖凝集素3单克隆抗体 | 7813 |
| D二聚体单克隆抗体 | 8189 |
| 肌钙蛋白单克隆抗体 | 8115 |
| 肌红蛋白单克隆抗体 | 7970 |
| AAT单克隆抗体 | 8135 |
| 人SAA单克隆抗体 | 7775 |
| 黏病毒抗性蛋白A单克隆抗体 | 7963 |
| 降钙素原单克隆抗体 | 7671 |
